< Back to previous page

Publication

Ablation therapy of postural orthostatic tachycardia syndrome, inappropriate sinus tachycardia and primary electrical diseases

Journal Contribution - Journal Article

Subtitle:new insights in invasive treatment options in severely symptomatic patients

Achieving the goal management of some arrhythmic syndromes can be challenging; medical treatment for inappropriate sinus tachycardia (IST) and postural orthostatic tachycardia syndrome (POTS) may be ineffective, necessitating multidisciplinary team treatment. Implantable defibrillator devices (ICDs), along with anti-arrhythmic drugs (AADs), remain the first-line treatment for primary electrical diseases that pose a risk of sudden cardiac death (SCD). Ablation of the arrhythmogenic substrate is not always suggested in patients with these pathologies, but it may be a valuable support for reducing arrhythmic burden, improving quality of life, and treating pathologies that are resistant to pharmacological treatment; however, this option is not often considered due to the potential risks associated with an invasive approach. Minimally invasive hybrid ablation in these syndromes, such as a hybrid thoracoscopic approach and the use of non-invasive mapping systems, reduces post-surgery complications and ensures the best possible outcome for the patient.

Journal: Herzschrittmachertherapie & Elektrophysiologie
ISSN: 0938-7412
Issue: 3
Volume: 32
Pages: 323-329
Publication year:2021
Keywords:Catheter Ablation, Death, Sudden, Cardiac, Defibrillators, Implantable, Humans, Postural Orthostatic Tachycardia Syndrome/diagnosis, Quality of Life, Tachycardia, Sinus/surgery
Accessibility:Closed